{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:24:58Z","timestamp":1793118298113,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T00:00:00Z","timestamp":1581984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T00:00:00Z","timestamp":1581984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hepatic fibrosis is a common pathological consequence of a sustained wound healing response to continuous liver injury, characterized by increased production and accumulation of extracellular matrix. If unresolved, the fibrotic process results in organ failure, and eventually death after the development of cirrhosis. It has been suggested that macrophages play central role in the progression of hepatic fibrosis, which is related to inflammation and pyroptosis, a novel programmed and proinflammatory cell death. However, it remains far less clear if, or how, lncRNAs regulates the activation and pyroptosis of macrophage in hepatic fibrosis. In the present study, we demonstrated that the liver-enriched lncRNA Lfar1, which has been reported to promote hepatic fibrosis through inducing hepatic stellate cells activation and hepatocytes apoptosis, was dysregulated during proinflammatory M1 activation and pyroptosis of macrophage. Our study revealed that silencing lnc-Lfar1 by a lentivirus-shRNA alleviated CCl<jats:sub>4<\/jats:sub>- and BDL-induced proinflammatory M1 macrophage activation and NLRP3 inflammasome-mediated pyroptosis. Furthermore, the in vitro experiments demonstrated that lnc-Lfar1 knockdown significantly suppressed LPS- and IFN-\u03b3-induced proinflammatory activation of macrophages, and inhibited LPS\/ATP- and LPS\/Nigericin-induced NLRP3 inflammasome-mediated pyroptosis. Mechanistically, lnc-Lfar1 regulated LPS- and IFN-\u03b3-induced proinflammatory activation of macrophages through the NF-\u0138B pathway. All these data supported our conclusion that lnc-Lfar1 plays a vital role in controlling the activation and pyroptosis of macrophage, thus providing a possible therapeutic target against inflammation-related disorders including hepatic fibrosis.<\/jats:p>","DOI":"10.1038\/s41419-020-2323-5","type":"journal-article","created":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T15:06:26Z","timestamp":1582038386000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":91,"title":["Silencing lncRNA Lfar1 alleviates the classical activation and pyoptosis of macrophage in hepatic fibrosis"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8916-556X","authenticated-orcid":false,"given":"Kun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhemin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guantong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,18]]},"reference":[{"key":"2323_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","volume":"121","author":"T Higashi","year":"2017","unstructured":"Higashi, T., Friedman, S. L. & Hoshida, Y. Hepatic stellate cells as key target in liver fibrosis. Adv. Drug Deliv. Rev. 121, 27\u201342 (2017).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"2323_CR2","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1055\/s-0037-1601350","volume":"37","author":"F Alegre","year":"2017","unstructured":"Alegre, F., Pelegrin, P. & Feldstein, A. E. Inflammasomes in liver fibrosis. Semin. Liver Dis. 37, 119\u2013127 (2017).","journal-title":"Semin. Liver Dis."},{"key":"2323_CR3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1172\/JCI88881","volume":"127","author":"Y Koyama","year":"2017","unstructured":"Koyama, Y. & Brenner, D. A. Liver inflammation and fibrosis. J. Clin. Invest. 127, 55\u201364 (2017).","journal-title":"J. Clin. Invest."},{"key":"2323_CR4","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nri.2017.11","volume":"17","author":"O Krenkel","year":"2017","unstructured":"Krenkel, O. & Tacke, F. Liver macrophages in tissue homeostasis and disease. Nat. Rev. Immunol. 17, 306\u2013321 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"2323_CR5","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.jhep.2017.02.026","volume":"66","author":"F Tacke","year":"2017","unstructured":"Tacke, F. Targeting hepatic macrophages to treat liver diseases. J. Hepatol. 66, 1300\u20131312 (2017).","journal-title":"J. Hepatol."},{"key":"2323_CR6","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.immuni.2016.02.015","volume":"44","author":"TA Wynn","year":"2016","unstructured":"Wynn, T. A. & Vannella, K. M. Macrophages in tissue repair, regeneration, and fibrosis. Immunity 44, 450\u2013462 (2016).","journal-title":"Immunity"},{"key":"2323_CR7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.lfs.2019.02.060","volume":"223","author":"H Guo","year":"2019","unstructured":"Guo, H., Xie, M., Zhou, C. & Zheng, M. The relevance of pyroptosis in the pathogenesis of liver diseases. Life Sci. 223, 69\u201373 (2019).","journal-title":"Life Sci."},{"key":"2323_CR8","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.tcb.2017.05.005","volume":"27","author":"SB Kovacs","year":"2017","unstructured":"Kovacs, S. B. & Miao, E. A. Gasdermins: effectors of pyroptosis. Trends Cell Biol. 27, 673\u2013684 (2017).","journal-title":"Trends Cell Biol."},{"key":"2323_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.biomaterials.2016.03.003","volume":"90","author":"Y Lu","year":"2016","unstructured":"Lu, Y. et al. CdSe\/ZnS quantum dots induce hepatocyte pyroptosis and liver inflammation via NLRP3 inflammasome activation. Biomaterials 90, 27\u201339 (2016).","journal-title":"Biomaterials"},{"key":"2323_CR10","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1002\/hep.26592","volume":"59","author":"A Wree","year":"2014","unstructured":"Wree, A. et al. NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice. Hepatology 59, 898\u2013910 (2014).","journal-title":"Hepatology"},{"key":"2323_CR11","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jhep.2017.11.040","volume":"68","author":"B Xu","year":"2018","unstructured":"Xu, B. et al. Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice. J. Hepatol. 68, 773\u2013782 (2018).","journal-title":"J. Hepatol."},{"key":"2323_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2014.06.043","volume":"547","author":"K Zhang","year":"2014","unstructured":"Zhang, K. et al. The ways of action of long non-coding RNAs in cytoplasm and nucleus. Gene 547, 1\u20139 (2014).","journal-title":"Gene"},{"key":"2323_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1829-1","volume":"10","author":"Y Zhao","year":"2019","unstructured":"Zhao, Y. et al. LncRNA NR_003923 promotes cell proliferation, migration, fibrosis, and autophagy via the miR-760\/miR-215-3p\/IL22RA1 axis in human Tenon\u2019s capsule fibroblasts. Cell Death Dis. 10, 594 (2019).","journal-title":"Cell Death Dis."},{"key":"2323_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1811-y","volume":"10","author":"Y Jia","year":"2019","unstructured":"Jia, Y. et al. LncRNA TTN-AS1 promotes migration, invasion, and epithelial mesenchymal transition of lung adenocarcinoma via sponging miR-142-5p to regulate CDK5. Cell Death Dis. 10, 573 (2019).","journal-title":"Cell Death Dis."},{"key":"2323_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1029-4","volume":"9","author":"F Yang","year":"2018","unstructured":"Yang, F. et al. Silencing long non-coding RNA Kcnq1ot1 alleviates pyroptosis and fibrosis in diabetic cardiomyopathy. Cell Death Dis. 9, 1000 (2018).","journal-title":"Cell Death Dis."},{"key":"2323_CR16","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.bbrc.2018.07.054","volume":"503","author":"X Han","year":"2018","unstructured":"Han, X., Hong, Y. & Zhang, K. TUG1 is involved in liver fibrosis and activation of HSCs by regulating miR-29b. Biochem. Biophys. Res. Commun. 503, 1394\u20131400 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2323_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09482-6","volume":"10","author":"P Zhang","year":"2019","unstructured":"Zhang, P., Cao, L., Zhou, R., Yang, X. & Wu, M. The lncRNA Neat1 promotes activation of inflammasomes in macrophages. Nat. Commun. 10, 1495 (2019).","journal-title":"Nat. Commun."},{"key":"2323_CR18","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.bbrc.2018.12.139","volume":"509","author":"Y Song","year":"2019","unstructured":"Song, Y. et al. Long noncoding RNA MALAT1 promotes high glucose-induced human endothelial cells pyroptosis by affecting NLRP3 expression through competitively binding miR-22. Biochem. Biophys. Res. Commun. 509, 359\u2013366 (2019).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2323_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00204-4","volume":"8","author":"K Zhang","year":"2017","unstructured":"Zhang, K. et al. The liver-enriched lnc-LFAR1 promotes liver fibrosis by activating TGFbeta and Notch pathways. Nat. Commun. 8, 144 (2017).","journal-title":"Nat. Commun."},{"key":"2323_CR20","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1002\/hep.27348","volume":"60","author":"H Shen","year":"2014","unstructured":"Shen, H. et al. Mouse hepatocyte overexpression of NF-kappaB-inducing kinase (NIK) triggers fatal macrophage-dependent liver injury and fibrosis. Hepatology 60, 2065\u20132076 (2014).","journal-title":"Hepatology"},{"key":"2323_CR21","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/hep.25711","volume":"56","author":"Y Sunami","year":"2012","unstructured":"Sunami, Y. et al. Hepatic activation of IKK\/NFkappaB signaling induces liver fibrosis via macrophage-mediated chronic inflammation. Hepatology 56, 1117\u20131128 (2012).","journal-title":"Hepatology"},{"key":"2323_CR22","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/hep4.1356","volume":"3","author":"A Guillot","year":"2019","unstructured":"Guillot, A. & Tacke, F. Liver macrophages: old dogmas and new insights. Hepatol. Commun. 3, 730\u2013743 (2019).","journal-title":"Hepatol. Commun."},{"key":"2323_CR23","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/hep.30249","volume":"69","author":"A Ambade","year":"2019","unstructured":"Ambade, A. et al. Pharmacological inhibition of CCR2\/5 signaling prevents and reverses alcohol-induced liver damage, steatosis, and inflammation in mice. Hepatology 69, 1105\u20131121 (2019).","journal-title":"Hepatology"},{"key":"2323_CR24","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/hep.29838","volume":"68","author":"X Li","year":"2018","unstructured":"Li, X. et al. Cholangiocyte-derived exosomal long noncoding RNA H19 promotes cholestatic liver injury in mouse and humans. Hepatology 68, 599\u2013615 (2018).","journal-title":"Hepatology"},{"key":"2323_CR25","doi-asserted-by":"crossref","unstructured":"Liu, R. et al. Cholangiocyte-derived exosomal long noncoding RNA H19 promotes hepatic stellate cell activation and cholestatic liver fibrosis. Hepatology 70, 1317\u20131335 (2019).","DOI":"10.1002\/hep.30662"},{"key":"2323_CR26","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1002\/hep.30698","volume":"70","author":"Y Xiao","year":"2019","unstructured":"Xiao, Y. et al. Long noncoding RNA H19 contributes to cholangiocyte proliferation and cholestatic liver fibrosis in biliary atresia. Hepatology 70, 1658\u20131673 (2019).","journal-title":"Hepatology"},{"key":"2323_CR27","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.omtn.2019.05.026","volume":"17","author":"F Yu","year":"2019","unstructured":"Yu, F. et al. Loss of lncRNA-SNHG7 promotes the suppression of hepatic stellate cell activation via miR-378a-3p and DVL2. Mol. Ther. Nucl. Acids 17, 235\u2013244 (2019).","journal-title":"Mol. Ther. Nucl. Acids"},{"key":"2323_CR28","doi-asserted-by":"publisher","first-page":"3622","DOI":"10.7150\/thno.32935","volume":"9","author":"K Zhang","year":"2019","unstructured":"Zhang, K. et al. SCARNA10, a nuclear-retained long non-coding RNA, promotes liver fibrosis and serves as a potential biomarker. Theranostics 9, 3622\u20133638 (2019).","journal-title":"Theranostics"},{"key":"2323_CR29","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/hep.29209","volume":"66","author":"Y Song","year":"2017","unstructured":"Song, Y. et al. H19 promotes cholestatic liver fibrosis by preventing ZEB1-mediated inhibition of epithelial cell adhesion molecule. Hepatology 66, 1183\u20131196 (2017).","journal-title":"Hepatology"},{"key":"2323_CR30","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1136\/gutjnl-2016-313314","volume":"66","author":"K Breitkopf-Heinlein","year":"2017","unstructured":"Breitkopf-Heinlein, K. et al. BMP-9 interferes with liver regeneration and promotes liver fibrosis. Gut 66, 939\u2013954 (2017).","journal-title":"Gut"},{"key":"2323_CR31","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1002\/hep.25545","volume":"55","author":"H Sahin","year":"2012","unstructured":"Sahin, H. et al. Chemokine Cxcl9 attenuates liver fibrosis-associated angiogenesis in mice. Hepatology 55, 1610\u20131619 (2012).","journal-title":"Hepatology"},{"key":"2323_CR32","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.cell.2018.03.064","volume":"173","author":"M Jiang","year":"2018","unstructured":"Jiang, M. et al. Self-recognition of an inducible host lncRNA by RIG-I feedback restricts innate immune response. Cell 173, 906\u2013919 (2018).","journal-title":"Cell"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2323-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2323-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2323-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T14:45:23Z","timestamp":1670251523000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2323-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,18]]},"references-count":32,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2]]}},"alternative-id":["2323"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-2323-5","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,18]]},"assertion":[{"value":"18 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"132"}}